Scarica l'app Stockscreener
63.75
1.02%
-0.66
Dopo l'orario di chiusura:
63.91
0.16
+0.25%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BMY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Bristol Myers Squibb Co Borsa (BMY) Ultime notizie
Bristol-Myers Squibb Co (BMY) Insider Sale: EVP, Chief Medical O - GuruFocus
BMY Gains 19.4% Year to Date: Should You Buy, Sell or Hold the Stock? - TradingView
Core Capital Management & Research inc. Invests $4.73 Million in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol-Myers Squibb (NYSE:BMY) Passes the Dividend Screen, but Payout Sustainability Is the Key Question - ChartMill
Allworth Financial LP Sells 91,375 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb stock heads into the open after a 3.2 percent drop - ad-hoc-news.de
Bristol-Myers Squibb stock heads into the open after a 3.2 percent drop - ad-hoc-news.de
Will The Recent Pipeline Progress Boost BMY's Portfolio Expansion? - Zacks Investment Research
What macro factors could move Bristol Myers Squibb (NYSE:BMY) shares this week? - Kalkine Media
National Coalition of Pharmaceutical Industry, Academic, and Nonprofit Partners Launches Fifth Winn CIPP Cohort - Finviz
Bristol Myers Squibb Company $BMY Shares Purchased by Waverly Advisors LLC - MarketBeat
CD&R Taps Former Bristol-Myers CEO Caforio in Healthcare Push - Bloomberg.com
Bristol Myers (NYSE: BMY) insider unloads 6,249 shares - Stock Titan
Bristol-Myers Squibb stock heads into the open after a 3.2% drop - ad-hoc-news.de
Bristol-Myers Squibb Co (BMY) Shares Fall 3.2% -- What GF Score of 71 Tells Investors - GuruFocus
Bristol Myers Squibb Co. stock underperforms Tuesday when compared to competitors - MarketWatch
Bristol-Myers Squibb Co Stock (BMY) Moved Down by 3.25% on Sep 8: Facts Behind the Movement - TradingKey
Bristol Myers' blood cancer cell therapy succeeds in mid-stage trial | Business Information & News | FE - Westlaw Today
What's Going On With Bristol Myers Stock Today?Bristol-Myers Squibb (NYSE:BMY) - Benzinga
Bristol Myers Squibb stock gains on positive arlocabtagene autoleucel trial results - AD HOC NEWS
Roivant surges on ‘exceptional’ results; Bristol Myers touts first-of-its-kind CAR-T therapy - Yahoo Finance
Bristol Myers' blood cancer cell therapy succeeds in mid-stage trial - Reuters
Bristol Myers' blood cancer cell therapy meets main goal in mid-stage trial - yahoo.com
Why Is Bristol Myers Squibb (NYSE:BMY) Under NYSE Focus Today? - Kalkine Media
Bristol Myers Squibb Company $BMY Shares Acquired by Amundi - MarketBeat
Bristol Myers Squibb stock heads into the open after a 1.9% slide - ad-hoc-news.de
Radioligand Therapy Market to Grow from USD 2.98 Billion in 2025 to USD 15.85 Billion by 2035, at a CAGR of 18.2% - GlobeNewswire Inc.
VIRGINIA RETIREMENT SYSTEMS ET Al Takes $99.23 Million Position in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol-Myers Squibb (BMY): Investor Outlook with a Focus on Dividend Yield and Strategic Collaborations - DirectorsTalk Interviews
TD Waterhouse Canada Inc. Buys 53,881 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Why Davy thinks Bristol-Myers Squibb’s latest rally is one to cash in on - Business Post
Saudi Central Bank Purchases 67,780 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb Company $BMY Shares Sold by Mid American Wealth Advisory Group Inc. - MarketBeat
Bristol-Myers Squibb (NYSE:BMY) Flashes Strong Technical Breakout Setup - ChartMill
Munich Reinsurance Co Stock Corp in Munich Raises Stock Position in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb Company $BMY Shares Purchased by NEOS Investment Management LLC - MarketBeat
Bristol Myers Squibb Company $BMY Position Boosted by Concurrent Investment Advisors LLC - MarketBeat
Atopic Dermatitis Drugs Market Set to Reach USD 33.42 Billion by 2035, at a CAGR of 7.70% - GlobeNewswire Inc.
Why Bristol Myers Squibb (BMY) Dipped More Than Broader Market Today - Yahoo Finance
Bristol Myers Squibb Co. stock underperforms Friday when compared to competitors - MarketWatch
Will Long‑Term Camzyos Data and Real‑World Evidence Change Bristol Myers Squibb's (BMY) Narrative? - simplywall.st
Will Camzyos' Long-Term Benefits Strengthen BMY's Growth Outlook? - TradingView
Bristol-Myers Squibb stock steadies as CAR-T trial pause meets strong Q2 2026 figures - AD HOC NEWS
A Wall Street Analyst Spotted the Trial Freeze—Then Came News of Three Deaths - Benzinga
Bristol Myers Squibb: Still Cheap, Despite What The Chart Says (NYSE:BMY) - Seeking Alpha
Bristol Myers Squibb: Buy The Growth Portfolio At A Value Price (NYSE:BMY) - Seeking Alpha
Bristol Myers Squibb Company $BMY Shares Bought by Burford Brothers Inc. - MarketBeat
Bristol Myers Squibb stock gains on Q2 beat and raised 2026 guidance - AD HOC NEWS
Bristol-Myers Squibb Stock: Is BMY Outperforming the Healthcare Sector? - Barchart.com
Revisiting Stock Picks Dexcom, Bristol Myers Squibb, Quanta Services - Barron's
Bristol Myers Squibb stock gains on CAR-T pause and Camzyos momentum - AD HOC NEWS
Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Autoimmune CAR-T faces tough questions after Novartis, Bristol Myers study halts - BioPharma Dive
Cellares downsizes New Jersey operations after losing BMS cell therapy contract - fiercepharma.com
Stripped of AstraZeneca safety net, BMS could face ‘carnage’ if high-risk clinical trial fails - BioSpace
Bristol-Myers Squibb stock holds the mid-$60 range - AD HOC NEWS
Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns - BioPharma Dive
Quantitative Investment Management LLC Makes New Investment in Bristol Myers Squibb Company $BMY - MarketBeat
Wellington Management Group LLP Has $225.53 Million Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
Benjamin Edwards Inc. Acquires 18,656 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Davidson Investment Advisors Sells 15,902 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Flputnam Investment Management Co. Purchases 26,360 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb (BMY) Unveils Five Year Camzyos Data At ESC Congress - simplywall.st
Opinion: Bristol Myers Squibb Is a Buy -- but the Real Reason Why Might Surprise Investors - The Motley Fool
Bristol Myers Squibb reports 97.4% of patients below heart blockage threshold - Stock Titan
Bristol Myers Squibb (BMY) Stock Looks Reasonable On Earnings Yet Strong Returns Test Value - Yahoo Finance
Archer Investment Corp Takes $1.40 Million Position in Bristol Myers Squibb Company $BMY - marketbeat.com
Bristol Myers Squibb (BMY) After ZENBEXUS Approval Faces A Fully Valued Debate - simplywall.st
Glenview Trust Co Invests $5.89 Million in Bristol Myers Squibb Company $BMY - MarketBeat
Jupiter Topco LLC Makes New Investment in Bristol Myers Squibb Company $BMY - marketbeat.com
0.47%
1.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):